- Scientists unveil benefits and risks of blockbuster weight-loss drugs Euronews
- Mapping the effectiveness and risks of GLP-1 receptor agonists Nature.com
- Sweeping review suggests weight-loss drugs’ effect on 175 conditions The Washington Post
- Weight-loss jabs linked to reduced risk of 42 conditions including dementia The Guardian
- Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind Livescience.com